Polytetrafluoroethylene (PTFE) Syringe Filters - SF18260
Mycoplasma contamination and submicron particle challenges in large-volume biological samples create critical bottlenecks where absolute sterility cannot be compromised yet immediate-use capability eliminates workflow delays. Traditional non-sterile mycoplasma filters require time-consuming sterilization steps that introduce contamination risks and extend processing timelines. Advanced hydrophilic PTFE membrane technology at 0.1μm eliminates these processing obstacles through validated mycoplasma retention combined with ready-to-use sterile packaging. Technical specifications include 29psi bubble point validation ensuring absolute 0.1μm retention, expanded 33mm platform with 4.9cm² filtration area, and 100μL holdup volume delivering 110ml throughput capacity with 12ml flow rates for demanding large-volume sterile processing workflows requiring immediate deployment and absolute mycoplasma-free assurance.
Key PTFE Membrane Characteristics
- Validated 0.1μm Mycoplasma Retention - Provides absolute removal of mycoplasma organisms and submicron contaminants with 29psi bubble point verification
- Hydrophilic Surface Engineering - Modified fluoropolymer technology eliminates pre-wetting procedures, enabling immediate aqueous sample processing
- Chemical Resistance Platform - Resists degradation from analytical solvents while maintaining documented incompatibility awareness for safe operation
- Low Protein Binding Technology - Maintains concentration of therapeutic proteins and biologics through minimal surface adsorption
- Engineered Membrane Depth - 80-140μm thickness provides structural stability while maintaining efficient 12ml flow characteristics
Key Construction Characteristics
- 100μL Holdup Volume - Minimizes loss through optimized dead space design, balancing sample recovery with large-volume processing efficiency
- Ready-to-Use Sterile Packaging - Individual sterile units eliminate contamination risks and pre-sterilization delays in critical workflows
- High-Capacity 33mm Platform - 4.9cm² effective area enables processing of large sample volumes up to 110ml capacity
- Integrated Polypropylene Prefilter - Extends membrane operational life through particulate protection while maintaining flow efficiency
Engineered for your demanding large-volume mycoplasma removal requirements, this hydrophilic PTFE system combines operational confidence through 87psi burst pressure ratings with validated submicron retention capabilities. Your laboratory achieves immediate sterile processing through ready-to-use packaging and maximizes throughput with a 110ml capacity. The robust prefilter construction ensures consistent Mycoplasma removal performance across challenging biological matrices and extended processing campaigns, where both high-volume capacity and absolute submicron particle retention are critical operational requirements.
For more information about chemical and material compatibility, please review our Chemical Compatibility Chart.
- Bubble Point (psi)
- 29psi
- Burst Pressure (psi)
- 87psi.
- Connection Type
- Luer-Lok/ Luer Slip
- Construction
- PP
- Diameter
- 33mm
- Filtration Area
- 4.9cm²
- Flow Rate
- 12ml
- Holdup Volume
- 100μL
- Incompatibility
- Bases, esters, ethers, ketones
- Material
- Polytetrafluoroethylene (PTFE)
- Maximum Operating Pressure
- 87psi
- Maximum Operating Temperature (°C)
- 60°C
- Membrane Thickness (µm)
- 80-140μm
- Pack Count
- 100
- Pore Size (µm)
- 0.1
- Prefilter (Yes/No)
- Yes
- Prefilter Material
- PP
- Sterility
- Sterile
- Volume Throughput (ml)
- 110ml
- Wetability
- Hydrophilic
- Biotechnology Scale-Up Processing - Removes mycoplasma from large-volume fermentation broths and cell culture harvests in process development
- Pharmaceutical Batch Testing - Sterilizes bulk samples for mycoplasma detection and sterility verification in manufacturing operations
- Clinical Research Large-Volume Processing - Filters biological specimens and therapeutic candidates requiring mycoplasma-free processing assurance
- Vaccine Production Intermediates - Provides mycoplasma removal for large-volume vaccine components and biological manufacturing streams
- Research Protein Purification - Clarifies and sterilizes protein solutions from expression systems requiring mycoplasma-free handling
- Quality Control Bulk Testing - Processes large sample volumes for mycoplasma testing and release procedures in pharmaceutical facilities